Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care

Abstract In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients' support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.

Calidad microbiológica del aire de una unidad de preparados farmacéuticos estériles / Bacteriological quality of air in a ward for sterile pharmaceutical preparations

Introducción: La elaboración de preparados farmacéuticos estériles requiere áreas limpias que deben cumplir estándares internacionales para minimizar la contaminación microbiana. Objetivo: Evaluar la calidad bacteriológica del aire de la Unidad de Preparados Farmacéuticos Estériles del Servicio de Farmacia del Hospital Clínico de la Universidad de Chile y establecer niveles de alerta y acción. Material y Métodos: Se monitorearon ocho puntos representativos de la unidad, diariamente entre enero y febrero de 2005 y bisemanal-mente de junio a febrero de 2006. Se estudiaron 839 muestras de aire, recolectadas mediante el método de impacto en placa (equipo MAS-100). Resultados: De las muestras estudiadas, 474 (56,5 por ciento) fueron positivas; de éstas, sólo 17 (3,5 por ciento) estuvieron fuera del rango permitido, porcentaje que representa el 2 por ciento del total. Las muestras de los sitios 1 y 2 (flujo laminar grande y pequeño), que corresponden al área de preparación de preparados estériles fueron negativas. Los sitios 3 (mesón) y 4 (transfer) presentaron ocasionalmente valores superiores a los límites. Los microorganismos más frecuentes fueron Staphylococcus coagulasa negativa, Micrococcus spp y Corynebacterium spp, agentes de la microbiota de la piel y, menor porcentaje, Bacillus spp, agente de la microbiota ambiental. Conclusiones: Desde el punto de vista microbiológico, la calidad del aire de la zona de preparaciones estériles descrita presenta niveles ajustados a estándares internacionales. El establecer niveles de alerta y acción institucionales y la identificación de los microorganismos obtenidos en las áreas más sensibles de la unidad permite cuantificar la carga microbiana y conocer sus componentes para determinar las intervenciones a realizar cuando ellas estén indicadas.

Background: An extremely clean area is required for preparation of sterile pharmaceutical compounds, in compliance with international standards, to minimize the probability of microbial contamination. Aim: To evaluate the bacteriological quality of the air in the Sterile Pharmaceutical Preparation Unit of the University of Chile's Clinical Hospital and to set up alerts and action levels of bacterial growth. Methods: We studied eight representative sites of our Unit on a daily basis from January to February 2005 and twice a week from June 2005 to February 2006. We collected 839 samples of air by impact in the Petri dish. Results: 474 (56.5 percent) samples were positive; 17 (3.5 percent) of them had an inappropriate bacterial growth (2 percent of total samples). The samples from sites 1 and 2 (big and small biosafety cabinets) were negative. The countertop and transfer area occasionally exceeded the bacterial growth limits. The most frequently isolated bacteria were coagulase-negative staphylococci, Micrococcus spp and Corynebacterium spp, from skin microbiota, and Bacillus spp, an environmental bacteria. Conclusions: From a microbiological perspective, the air quality in our sterile preparation unit complied with international standards. Setting institutional alerts and action levels and appropriately identifying bacteria in sensitive areas permits quantification of the microbial load and application of preventive measures.